donanemab

Alzheimer’s drugs are not the breakthrough promised: Review

A review of more than 20,000 participants found that plaque‑clearing Alzheimer’s drugs offer minimal clinical benefit and carry notable safety…

Year in review: Dementia breakthroughs

Dementia has surpassed heart disease to become the leading cause of death in Australia, a statistic confirmed by the Australian…

No PBS for new Alzheimer’s therapy

The Pharmaceutical Benefits Advisory Committee has rejected an application for a newly approved Alzheimer’s treatment to be included on the…

New Alzheimer’s drug trial shows promising results

New results from a medical trial have revealed that a new drug may be able to slow the progression of…